Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: A center for international blood and marrow transplant research analysis Academic Article uri icon

Overview

MeSH Major

  • Cyclophosphamide
  • HLA Antigens
  • Haploidy
  • Hematopoietic Stem Cell Transplantation
  • Histocompatibility
  • Immunosuppressive Agents
  • Lymphoma
  • Siblings
  • Tissue Donors
  • Transplantation Conditioning

abstract

  • Haplo-HCT with PT-Cy provides survival outcomes comparable to MSD-HCT, with a significantly lower risk of chronic GVHD.

publication date

  • September 10, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5012706

Digital Object Identifier (DOI)

  • 10.1200/JCO.2015.66.3476

PubMed ID

  • 27269951

Additional Document Info

start page

  • 3141

end page

  • 9

volume

  • 34

number

  • 26